Gonapeptyl Daily (Triptorelin Acetate)

Gonapeptyl Daily is indicated for several hormone‑dependent disorders in which medical suppression of gonadal steroid production is required, providing a reversible option for adult patients under specialist supervision.

• Androgen deprivation therapy for advanced prostate cancer to slow disease progression.
• Hormone suppression for endometriosis to reduce pelvic pain and lesion growth.
• Treatment of central precocious puberty to delay secondary sexual development.
• Adjunct therapy for uterine fibroids to shrink size and lessen bleeding.
• Use in assisted reproductive technology for controlled ovarian stimulation and timing of oocyte retrieval.
• Pre‑operative hormonal down‑staging in selected hormone‑sensitive cancers to improve surgical outcomes.

Side‑effect profiles for Gonapeptyl Daily reflect its hormonal activity and may vary among individuals, often appearing during the initial weeks of treatment.

Common

• Hot flashes or sweating.
• Headache and fatigue.
• Injection site reactions such as redness, swelling, or mild pain.
• Nausea or mild gastrointestinal discomfort.

Serious

• Severe allergic reaction (anaphylaxis) with rash, swelling, or breathing difficulty.
• Cardiovascular events such as hypertension, thrombosis, or stroke.
• Significant loss of bone mineral density leading to osteoporosis.
• Marked elevation of liver enzymes indicating hepatic injury.

Before starting Gonapeptyl Daily, clinicians should assess several precautionary factors to ensure safe use and monitor for potential complications.

• Evaluate cardiovascular risk, especially in patients with hypertension or a history of thromboembolic disease.
• Assess bone health, as prolonged therapy may increase the risk of osteoporosis or fractures.
• Screen for liver disease, since hepatic impairment can affect drug metabolism and increase toxicity.
• Discuss fertility intentions; treatment suppresses gonadal function and recovery may take several months after discontinuation.
• Monitor blood glucose in diabetic patients, as hormonal changes can affect glycemic control.
• Use caution in individuals with a history of severe depression or other psychiatric disorders.

Gonapeptyl Daily can interact with other medicines that influence hormonal pathways, cardiovascular function, or drug metabolism, requiring careful management.

Avoid

• Concurrent use with other GnRH agonists or antagonists, which may cause excessive hormone suppression.
• Strong CYP3A4 inducers that could reduce triptorelin plasma concentrations and efficacy.

Use with caution

• Anticoagulant therapy, as hormonal changes may alter coagulation risk.
• Hormone replacement therapy, which may counteract the intended suppression.
• Medications that prolong the QT interval, given potential cardiac effects.